Hepatitis B vaccine shortage continues FDA committees split on rosiglitazoneMarket withdrawal is most popular option, but not a majority vote Canadian researchers disagree on halting rosiglitazone trial Canadian researchers disagree on halting trial of diabetes drug rosiglitazone New treatment on horizon for involuntary outbursts Combo drug offers alternative to off-label antidepressants for pseudobulbar affect Cervarix: second HPV vaccine approved in Canada Is this a game changer for Big Pharma? GSK may be spearheading an “open-source” movement Meningitis: symptoms, management and prevention Raising public awareness and providing education on symptoms, management and prevention Anaphylaxis fears prompt H1N1 vaccine recall Avamys approved for children Ontario study reheats rosiglitazone controversy Research recommends avoiding the medication due to cardiovascular risks First Previous 15 16 17 18 Next Last
